Skip to main content
  • AACR Journals
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Radiation Oncology
      • Novel Combinations
      • Reviews
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Journals
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Cancer Therapeutics
Molecular Cancer Therapeutics
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Radiation Oncology
      • Novel Combinations
      • Reviews
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Research Articles

Cul3 overexpression depletes Nrf2 in breast cancer and is associated with sensitivity to carcinogens, to oxidative stress, and to chemotherapy

Martin Loignon, Weimin Miao, Lianggao Hu, Andrew Bier, Tarek A. Bismar, P. James Scrivens, Koren Mann, Mark Basik, Amélie Bouchard, Pierre O. Fiset, Zachary Batist and Gerald Batist
Martin Loignon
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Weimin Miao
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lianggao Hu
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrew Bier
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tarek A. Bismar
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
P. James Scrivens
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Koren Mann
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mark Basik
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Amélie Bouchard
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pierre O. Fiset
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zachary Batist
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gerald Batist
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1158/1535-7163.MCT-08-1186 Published August 2009
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Online Impact

Statistics from Altmetric.com

ARTICLE USAGE

ARTICLE USAGE: July 2009 to March 2021

AbstractFull-text HTMLPDF
Total334155253248

Cited By

Article Information

Volume 8, Issue 8, pp. 2432-2440

DOI 
https://doi.org/10.1158/1535-7163.MCT-08-1186
PubMed 
19638449

Published By 
American Association for Cancer Research
Print ISSN 
1535-7163
Online ISSN 
1538-8514
History 
  • Received August 27, 2008
  • Revision received March 19, 2009
  • Accepted March 31, 2009
  • Published first July 28, 2009.

Article Versions

  • Previous version (July 28, 2009 - 09:08).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© 2009 American Association for Cancer Research.

Author Information

  1. Martin Loignon1,
  2. Weimin Miao3,
  3. Lianggao Hu1,
  4. Andrew Bier1,
  5. Tarek A. Bismar1,2,
  6. P. James Scrivens1,
  7. Koren Mann1,
  8. Mark Basik1,
  9. Amélie Bouchard1,
  10. Pierre O. Fiset1,
  11. Zachary Batist1 and
  12. Gerald Batist1
  1. 1Segal Cancer Centre, Sir Mortimer B. Davis-Jewish General Hospital, and Departments of Oncology and 2Pathology McGill University, 3755 Cote Sainte Catherine Road, Montréal, Québec, Canada; and 3Molecular Imaging and Translational Research Program, University of Tennessee, Graduate School of Medicine, Knoxville, Tenessee
  1. Requests for reprints:
    Gerald Batist, Segal Cancer Centre, Jewish General Hospital, 3755 Cote Sainte Catherine Road, Montréal, Québec, Canada, H3T 1E2. Phone: 514-340-8222, ext. 5418. Fax: 514-735-7211. E-mail: gbatist{at}onc.jgh.mcgill.ca
View Full Text
PreviousNext
Back to top
Molecular Cancer Therapeutics: 8 (8)
August 2009
Volume 8, Issue 8
  • Table of Contents
  • About the Cover

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Cancer Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Cul3 overexpression depletes Nrf2 in breast cancer and is associated with sensitivity to carcinogens, to oxidative stress, and to chemotherapy
(Your Name) has forwarded a page to you from Molecular Cancer Therapeutics
(Your Name) thought you would be interested in this article in Molecular Cancer Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Cul3 overexpression depletes Nrf2 in breast cancer and is associated with sensitivity to carcinogens, to oxidative stress, and to chemotherapy
Martin Loignon, Weimin Miao, Lianggao Hu, Andrew Bier, Tarek A. Bismar, P. James Scrivens, Koren Mann, Mark Basik, Amélie Bouchard, Pierre O. Fiset, Zachary Batist and Gerald Batist
Mol Cancer Ther August 1 2009 (8) (8) 2432-2440; DOI: 10.1158/1535-7163.MCT-08-1186

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Cul3 overexpression depletes Nrf2 in breast cancer and is associated with sensitivity to carcinogens, to oxidative stress, and to chemotherapy
Martin Loignon, Weimin Miao, Lianggao Hu, Andrew Bier, Tarek A. Bismar, P. James Scrivens, Koren Mann, Mark Basik, Amélie Bouchard, Pierre O. Fiset, Zachary Batist and Gerald Batist
Mol Cancer Ther August 1 2009 (8) (8) 2432-2440; DOI: 10.1158/1535-7163.MCT-08-1186
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Disclosure of Potential Conflicts of Interest
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • A Novel TRAIL-Based Technology for Tumor Therapy
  • Trastuzumab Targeting of Metastatic Esophageal Cancer
  • Mcl-1 Determines the Fate of KSP-Inhibited Cells
Show more Research Articles
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About MCT

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Molecular Cancer Therapeutics
eISSN: 1538-8514
ISSN: 1535-7163

Advertisement